The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Feature|Articles|March 2, 2024
- Pharmaceutical Technology, March 2024
- Volume 48
- Issue 3
- Pages: 10
Bioprocess Controller
Author(s)Pharmaceutical Technology Editors
Distek has released the BIOne 250 Bioprocess Controller, designed for microbial applications.
Distek has released the BIOne 250 Bioprocess Controller, designed for microbial applications. It is a process-optimized version of the BIOne 1250 benchtop bioreactor system, offering an approachable solution to meet the nuanced requirements of advanced microbial bioprocessing. The controller retains the user interface of the BIOne 1250 via a remote personal computer or monitor, supporting the management of multiple bioreactors from a single central screen.
A standout feature of the BIOne 250 is its scalability, which accommodates the evolving needs of bioprocess applications, making it suitable for scale-down modeling, material generation, and process optimization. The controller is designed for reliability and precision, ensuring consistent and accurate results throughout experiments. The budget-friendly price for the BIOne 250 is intended to make advanced bioprocess control more accessible without sacrificing functionality and quality.
Articles in this issue
over 2 years ago
Reshaping Dosage Formsover 2 years ago
Development of Gamma-Delta T-Cell Therapiesover 2 years ago
Automating the Future of Fill/Finishover 2 years ago
Frontrunners in Bispecific Antibodiesover 2 years ago
Updating Swiss Regulatory Processes in 2024over 2 years ago
Budget Benefitover 2 years ago
First in Line on Catalent’s LineRelated to this article
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.